Transparency Market Research has published a new report on the global pain management therapeutics market. As per the report, the global pain management therapeutics market is expected to decline from US$40.9 bn in 2011 to US$29.5 bn by 2018. The report, titled ‘Pain Management Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018,’ states that the global pain management therapeutics market is predicted to decline at a -5.50% CAGR from 2012 to 2018 owing to increasing patient expiry of blockbuster drugs.
Browse the full Pain Management Therapeutics Market (Anticonvulsants, Antidepressants, Anesthetics, NSAIDs, Opioids, Other Non-Narcotic Analgesics and Anti-Migraine Agents) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018 report at http://www.transparencymarketresearch.com/pain-management-therapeutics.html
Chronic pain is a very common health concern in all regions across the globe. Due to the ill effects of chronic pain, there has been an increase in the demand for pain management therapeutics. The global pain management therapeutics market offers many methods or therapies of pain management such as physiotherapy, minimally invasive procedures, and chiropractor therapy. Pharmaceuticals including analgesics and painkillers are the initial treatments commonly prescribed by physicians. This includes drugs that belong to therapeutic classes such as non-steroidal anti-inflammatory drugs, anticonvulsants, anti-migraine agents, opioids, and others.
While the global pain management therapeutics market is progressing considerably, it is expected to be affected by the expiry of blockbuster drugs. Patent expiry of blockbuster drugs including Cymbalta of Eli Lilly & Co. and Lyrica of Pfizer, Inc. was a major setback for the global pain management therapeutics market. The loss of market exclusiveness of blockbuster drugs has further reduced the revenue made in the global pain management therapeutics market. This has created an opportunity for generic drug manufacturers to take a step forward. Insufficiency in the discovery of novel drugs is expected to weaken the growth of the global pain management therapeutics market. In the years to come, manufacturers are expected to invest more funds in the production of novel drugs.
The global pain management therapeutics market is segmented on the basis of therapeutic class, indication, and geography. Based on therapeutic class, the global pain management market is classified into anticonvulsants, NSAIDs, opioids, anesthetics, antidepressants, anti-migraine agents, and other non-narcotic analgesics. In 2011, the NSAIDs segment dominated the global pain management therapeutics market owing to factors such as the rising incidence of diabetes and cancer.
Based on geography, the global pain management therapeutics market is divided into Europe, Asia Pacific, North America, and Rest of the Globe. In 2011, the North America pain management therapeutics market was valued at US$21.7 bn and is predicted to decline to US$14.3 bn by 2018. In terms of market attractiveness and growth, Asia Pacific and Rest of the World are predicted to be the fastest developing markets in the global pain management therapeutics market.
By indication, the global pain management therapeutics market is classified into neuropathic pain, fibromyalgia, arthritic pain, chronic back pain, cancer pain, migraine, and chronic back pain.
Some of the leading companies operating in the global pain management therapeutics market are Abbott Laboratories, Inc., Eli Lilly & Co., Johnson & Johnson, Pfizer, Inc., AstraZeneca PLC, Endo Health Solutions, Merck & Co., Inc., and Purdue Pharma LP.
Key Segments of Global Pain Management Therapeutics Market
Pain Management Therapeutics Market, by Therapeutic Class
- Other Non-Narcotic Analgesics (Acetaminophen)
- Anti-Migraine Agents
Pain Management Therapeutics Market, by Indication
- Neuropathic Pain
- Arthritic Pain, by Type
- Rheumatoid Arthritis
- Chronic Back Pain
- Post-operative Pain
- Cancer Pain
Pain Management Therapeutics Market, by Geography
- North America
- Rest of the World (RoW)
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453